StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
ICON Public Limited Company
NasdaqGS:ICLR
Sector
Industries
Location
Market Cap
USD 11.41 B
Share Price
USD 143.54
Avg Daily Volume
1,551,715
Change (1 day)
-2.27%
Change (1 year)
-56.21%
Change (YTD)
-31.55%
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 17.63%
ICON Public Limited Company EBITDA Margin is 17.63% for the Trailing 12 Months (TTM) ending March 31, 2025, a -12.08% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 20.06%, a 5.70% change year over year.
-
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 18.97%, a 33.59% change year over year.
-
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 14.20%, a -15.44% change year over year.
-
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 16.80%, a -8.24% change year over year.
Competitors
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Siemens Healthineers AG
USD 53.60
SHL.DE
-0.42
-0.77%
GE HealthCare Technologies Inc.
USD 75.96
GEHC
-0.28
-0.37%
Laboratory Corporation of America Holdings
USD 243.72
LH
-3.52
-1.42%
Natera, Inc.
USD 138.90
NTRA
-4.48
-3.12%
Baxter International Inc.
USD 27.77
BAX
-0.12
-0.43%
Torrent Pharmaceuticals Limited
USD 40.86
TORNTPHARM.NS
+0.16
0.38%
Ascendis Pharma A/S
USD 169.90
ASND
-7.30
-4.12%
Exact Sciences Corporation
USD 50.46
EXAS
-1.75
-3.35%
Regencell Bioscience Holdings Limited
USD 14.50
RGC
-0.36
-2.42%
ConvaTec Group Plc
USD 3.19
CTEC.L
-0.05
-1.54%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.51
3347.HK
+0.08
1.30%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.60
300832.SZ
+0.03
0.35%
Guardant Health, Inc.
USD 46.46
GH
-0.82
-1.73%
DiaSorin S.p.A.
USD 105.21
DIA.MI
+0.62
0.59%
APT Medical Inc.
USD 40.39
688617.SS
-0.15
-0.37%
Laurus Labs Limited
USD 9.60
LAURUSLABS.NS
+0.05
0.57%
Lantheus Holdings, Inc.
USD 70.18
LNTH
-3.42
-4.65%
Ipca Laboratories Limited
USD 17.07
IPCALAB.NS
-0.05
-0.30%
ADMA Biologics, Inc.
USD 16.73
ADMA
-0.86
-4.89%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Siemens Healthineers AG
USD 53.60
SHL.DE
-0.42
-0.77%
GE HealthCare Technologies Inc.
USD 75.96
GEHC
-0.28
-0.37%
Laboratory Corporation of America Holdings
USD 243.72
LH
-3.52
-1.42%
Natera, Inc.
USD 138.90
NTRA
-4.48
-3.12%
Baxter International Inc.
USD 27.77
BAX
-0.12
-0.43%
Torrent Pharmaceuticals Limited
USD 40.86
TORNTPHARM.NS
+0.16
0.38%
Ascendis Pharma A/S
USD 169.90
ASND
-7.30
-4.12%
Exact Sciences Corporation
USD 50.46
EXAS
-1.75
-3.35%
Regencell Bioscience Holdings Limited
USD 14.50
RGC
-0.36
-2.42%
ConvaTec Group Plc
USD 3.19
CTEC.L
-0.05
-1.54%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.51
3347.HK
+0.08
1.30%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.60
300832.SZ
+0.03
0.35%
Guardant Health, Inc.
USD 46.46
GH
-0.82
-1.73%
DiaSorin S.p.A.
USD 105.21
DIA.MI
+0.62
0.59%
APT Medical Inc.
USD 40.39
688617.SS
-0.15
-0.37%
Laurus Labs Limited
USD 9.60
LAURUSLABS.NS
+0.05
0.57%
Lantheus Holdings, Inc.
USD 70.18
LNTH
-3.42
-4.65%
Ipca Laboratories Limited
USD 17.07
IPCALAB.NS
-0.05
-0.30%
ADMA Biologics, Inc.
USD 16.73
ADMA
-0.86
-4.89%